EZH2 inhibitor SHR2554 enhances the anti-tumor efficacy of HDAC inhibitor Chidamide through STAT1 in T-cell lymphoma. - Wu J; Hu D; Yu H; Wang D; Ye Y; Cao J; Pan T; Mi L; Song Y; Wu M; Ping L; Zhu J (Cell death & disease, 2025)